[{"id":"46aa98a6-cba9-44da-9bfb-8a499b69e25d","acronym":"","url":"https://clinicaltrials.gov/study/NCT02671890","created_at":"2024-02-12T16:24:54.341Z","updated_at":"2024-07-02T16:35:19.826Z","phase":"Phase 1","brief_title":"Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer","source_id_and_acronym":"NCT02671890","lead_sponsor":"Mayo Clinic","biomarkers":" STAT3 • EGR1 • SOCS3","pipe":"","alterations":" ","tags":["STAT3 • EGR1 • SOCS3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 16","initiation":"Initiation: 02/25/2016","start_date":" 02/25/2016","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 05/05/2025","study_completion_date":" 05/05/2025","last_update_posted":"2024-02-12"},{"id":"156d54c5-8d8f-476f-89e1-cf5c28672101","acronym":"","url":"https://clinicaltrials.gov/study/NCT05098327","created_at":"2021-10-28T17:56:21.946Z","updated_at":"2024-07-02T16:35:39.988Z","phase":"Phase 3","brief_title":"Pioglitazone and Insulin Resistance in ADT","source_id_and_acronym":"NCT05098327","lead_sponsor":"State University of New York at Buffalo","biomarkers":" AKT2 • IRS1 • TLR4 • MAPK8 • SOCS3","pipe":"","alterations":" ","tags":["AKT2 • IRS1 • TLR4 • MAPK8 • SOCS3"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2021","start_date":" 08/01/2021","primary_txt":" Primary completion: 03/31/2023","primary_completion_date":" 03/31/2023","study_txt":" Completion: 03/31/2023","study_completion_date":" 03/31/2023","last_update_posted":"2023-08-15"},{"id":"295be39e-2ac7-43c4-a67b-69e2dade9e78","acronym":"","url":"https://clinicaltrials.gov/study/NCT01245231","created_at":"2021-01-18T05:00:54.840Z","updated_at":"2024-07-02T16:37:32.064Z","phase":"","brief_title":"Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT01245231","lead_sponsor":"Children's Oncology Group","biomarkers":" IL6 • SOCS3","pipe":"","alterations":" ","tags":["IL6 • SOCS3"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 05/01/2010","start_date":" 05/01/2010","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":"","study_completion_date":"","last_update_posted":"2016-05-18"}]